Northern Trust Corp Has $9.83 Million Holdings in Chimera Investment Corporation $CIM

Northern Trust Corp lessened its position in shares of Chimera Investment Corporation (NYSE:CIM) by 4.3% during the 1st quarter, Holdings Channel.com reports. The firm owned 766,185 shares of the real estate investment trust’s stock after selling 34,653 shares during the quarter. Northern Trust Corp’s holdings in Chimera Investment were worth $9,830,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. GAMMA Investing LLC grew its holdings in shares of Chimera Investment by 8,728.6% during the 1st quarter. GAMMA Investing LLC now owns 3,708 shares of the real estate investment trust’s stock worth $48,000 after purchasing an additional 3,666 shares in the last quarter. Motiv8 Investments LLC acquired a new stake in shares of Chimera Investment during the 1st quarter worth approximately $131,000. Sigma Planning Corp acquired a new stake in shares of Chimera Investment during the 1st quarter worth approximately $131,000. PharVision Advisers LLC acquired a new stake in shares of Chimera Investment during the 4th quarter worth approximately $178,000. Finally, Vident Advisory LLC acquired a new stake in shares of Chimera Investment during the 4th quarter worth approximately $184,000. Institutional investors and hedge funds own 48.44% of the company’s stock.

Chimera Investment Price Performance

Chimera Investment stock opened at $14.73 on Friday. The company has a debt-to-equity ratio of 4.47, a quick ratio of 4.14 and a current ratio of 4.14. The firm has a market cap of $1.19 billion, a P/E ratio of 11.69 and a beta of 1.85. The business’s fifty day moving average is $13.91 and its two-hundred day moving average is $13.31. Chimera Investment Corporation has a 52 week low of $9.85 and a 52 week high of $16.89.

Chimera Investment (NYSE:CIM) last posted its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $0.39 EPS for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.07). The business had revenue of $66.01 million during the quarter, compared to analyst estimates of $83.89 million. Chimera Investment had a return on equity of 7.28% and a net margin of 21.93%. Equities research analysts forecast that Chimera Investment Corporation will post 1.57 earnings per share for the current fiscal year.

Chimera Investment Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, July 31st. Shareholders of record on Monday, June 30th were paid a $0.37 dividend. The ex-dividend date of this dividend was Monday, June 30th. This represents a $1.48 dividend on an annualized basis and a yield of 10.1%. Chimera Investment’s payout ratio is currently 117.46%.

Analysts Set New Price Targets

Several analysts recently commented on the company. UBS Group boosted their price target on Chimera Investment from $15.00 to $16.00 and gave the company a “buy” rating in a research note on Thursday, July 10th. Keefe, Bruyette & Woods decreased their price target on Chimera Investment from $16.50 to $15.00 and set a “market perform” rating on the stock in a research note on Thursday, July 10th. Finally, Wall Street Zen lowered Chimera Investment from a “hold” rating to a “sell” rating in a research note on Saturday, August 9th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Chimera Investment has an average rating of “Hold” and an average target price of $15.50.

Chimera Investment Company Profile

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.